-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Efbemalenograstim Alfa LA in Peritoneal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Efbemalenograstim Alfa LA in Peritoneal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Efbemalenograstim Alfa LA in Peritoneal Cancer Drug Details: Efbemalenograstim...
-
Innovation Ranking
Innovation Ranking – La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company (La Jolla) discovers, develops and commercializes biopharmaceutical products for life-threatening diseases. The company’s major product includes the US FDA approved Giapreza, an injection for intravenous infusion indicated to increase blood pressure in adults with septic or other distributive shock and Xerava (eravacycline), is an injection of tetracycline class antibacterial for the treatment of complicated intra-abdominal infections (cIAI) in adults. Its investigational product candidates include LJPC-0118 intended for the treatment of severe malaria and LJPC-401, a proprietary...
-
Innovation Ranking
Innovation Ranking – La-Z-Boy Inc
La-Z-Boy Inc (La-Z-Boy) is a furniture company that manufactures, markets, imports, distributes, and retails upholstery products, accessories, and case goods furniture related products. La-Z-Boy markets its products under La-Z-Boy, Kincaid, American Drew and Hammary brand names. The comapany sells its products through a network of La-Z-Boy Furniture Galleries stores, Comfort Studios and other dealers. Its product portfolio includes recliners and motion furniture, sofas, loveseats, chairs, ottomans, sleepers, sectionals, tables, entertainment centers, bedroom sets, dining room sets and accent pieces. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Somatropin Pegol LA in Growth Hormone Deficiency
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Somatropin Pegol LA in Growth Hormone Deficiency report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Somatropin Pegol LA in Growth Hormone Deficiency Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ravulizumab LA in IgA Nephropathy (Berger’s Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ravulizumab LA in IgA Nephropathy (Berger's Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ravulizumab LA in IgA Nephropathy (Berger's Disease) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Efbemalenograstim Alfa LA in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Efbemalenograstim Alfa LA in Fallopian Tube Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Efbemalenograstim Alfa LA in Fallopian Tube Cancer Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Efbemalenograstim Alfa LA in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Efbemalenograstim Alfa LA in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Efbemalenograstim Alfa LA in Epithelial Ovarian Cancer Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ropeginterferon Alfa-2b LA in Hepatitis B
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ropeginterferon Alfa-2b LA in Hepatitis B report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ropeginterferon Alfa-2b LA in Hepatitis B Drug Details: Ropeginterferon...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Octreotide LA in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Octreotide LA in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Octreotide LA in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Drug...
-
Innovation Ranking
Innovation Ranking – F. Hoffmann-La Roche Ltd
F. Hoffmann-La Roche Ltd (Roche) is a biotechnology company that develops drugs and diagnostics to treat major diseases. It provides medicines for the treatment of cancer, other auto-immune diseases, central nervous system disorders, ophthalmological disorders, infectious diseases, and respiratory diseases. The company also offers in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. Roche conducts research to identify novel methods to prevent, diagnose, and treat diseases. The company offers its products and services to hospitals, healthcare professionals, commercial laboratories,...